Geron | GERN - EPS Earnings Per Share

Stock Price
1.29
Daily Change
-0.11 -7.86%
Monthly
-23.67%
Yearly
1.57%
Q2 Forecast
1.26

Geron reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.01 -0.02 -0.03 May/06
FY2025Q4 Dec/2025 -0.05 -0.03 -0.04 Feb/25
FY2025Q3 Sep/2025 -0.03 -0.03 -0.04 Nov/05
FY2025Q2 Jun/2025 -0.02 -0.03 -0.10 Aug/06
FY2025Q1 Mar/2025 -0.03 -0.03 -0.09 May/07




Eps Change Date
Amgen USD 5.15 0.14 Mar/2026
Bio Techne USD 0.53 0.07 Mar/2026
Cassava Sciences USD -0.26 0.04 Dec/2025
Cytokinetics USD -1.67 0.17 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Exelixis USD 0.87 0.1 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
Geron USD -0.01 0.04 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025